Pancreatic Cancer Research

ResearcherDalian Medical UniversityActive in the last 2 years

Shilin Xia

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1187-3192; OpenAlex author ID A5028526313. Sources: OpenAlex.

Their work

Papers
9 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
23
Papers, trials and grants by year

2019: 1 paper · 2020: 3 papers · 2021: 1 paper · 2022: none · 2023: 2 papers · 2024: 1 paper · 2025: 1 paper

Papers 9

  1. The Molecular Characteristics and Therapeutic Implications of O-glycan Synthesis in Pancreatic Cancer by Integrating Transcriptome and Single-cell Data. Co-author DOI 10.2174/0109298673293445240409060446↗
  2. Identification of basement membrane-related prognostic model associated with the immune microenvironment and synthetic therapy response in pancreatic cancer: i… Co-author DOI 10.7150/jca.100891↗
  3. Identifying endoplasmic reticulum stress-related molecular subtypes and prognostic model for predicting the immune landscape and therapy response in pancreatic… Co-author DOI 10.18632/aging.205094↗
  4. Identification and characterization of interferon-γ signaling-based personalized heterogeneity and therapeutic strategies in patients with pancreatic cancer. Co-author DOI 10.3389/fonc.2023.1227606↗
  5. An immune-related lncRNA signature for the prognosis of pancreatic adenocarcinoma. Last author DOI 10.18632/aging.203323↗
  6. The potential drug for treatment in pancreatic adenocarcinoma: a bioinformatical study based on distinct drug databases. Last author DOI 10.1186/s13020-020-00309-x↗
  7. T Lymphocytes: A Promising Immunotherapeutic Target for Pancreatitis and Pancreatic Cancer? Co-author DOI 10.3389/fonc.2020.00382↗
  8. The nine ADAMs family members serve as potential biomarkers for immune infiltration in pancreatic adenocarcinoma. Last author DOI 10.7717/peerj.9736↗
  9. Bioinformatic evidences and analysis of putative biomarkers in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.heliyon.2019.e02378↗

Closest collaborators

The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Biao Zhang · 3 shared papers, 2023–2025 · strength 0.66
  2. Dong Shang · 3 shared papers, 2023–2025 · strength 0.63
  3. Han Liu · 4 shared papers, 2019–2021 · strength 0.45
  4. Qihang Yuan · 2 shared papers, 2023–2025 · strength 0.44
  5. Fangyue Guo · 3 shared papers, 2020–2023 · strength 0.42
  6. Xueying Shi · 3 shared papers, 2020–2023 · strength 0.42
  7. Xu Chen · 2 shared papers, 2023 · strength 0.37
  8. Bing Qi · 3 shared papers, 2020–2021 · strength 0.35
  9. Qi Zhou · 2 shared papers, 2020–2021 · strength 0.26
  10. Binqian Huang · 1 shared paper, 2025 · strength 0.26
  11. Jifeng Liu · 1 shared paper, 2025 · strength 0.26
  12. Huiyi Song · 1 shared paper, 2024 · strength 0.22
  13. Dong Shang · 1 shared paper, 2024 · strength 0.22
  14. Zhizhou Wang · 1 shared paper, 2023 · strength 0.18
  15. Ji Li · 1 shared paper, 2021 · strength 0.13
  16. Yajun Gu · 1 shared paper, 2021 · strength 0.13
  17. Hong Xiang · 1 shared paper, 2020 · strength 0.13
  18. Xufeng Tao · 1 shared paper, 2020 · strength 0.13
  19. Dong Shang · 1 shared paper, 2020 · strength 0.13
  20. Lei Yao · 1 shared paper, 2020 · strength 0.11
  21. Yuan Yuan Ma · 1 shared paper, 2020 · strength 0.11
  22. Yuan Gu · 1 shared paper, 2019 · strength 0.10
  23. Hiroyuki Kobayashi · 1 shared paper, 2019 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.